Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Advanced fibrosis, TP53 variants and acute/pure erythroid leukaemia: Diagnostic harbingers of ERCC6L2-related bone marrow failure syndrome?
Journal: British journal of haematology
Published: July 08, 2026
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat β-Thalassemia.
Journal: The New England journal of medicine
Published: April 03, 2026
CRE25-042: Advanced Fibrosis, TP53 Variants, and Erythroid Differentiation: Diagnostic Harbingers of ERCC6L2-Related Bone Marrow Failure Syndrome?
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2025
Allogeneic Hematopoietic Cell Transplant For Bone Marrow Failure or Myelodysplastic Syndrome in Dyskeratosis Congenita/Telomere Biology Disorders: Single-Center, Single-Arm, Open-Label Trial of Reduced-Intensity Conditioning Without Radiation.
Journal: Transplantation and cellular therapy
Published: March 28, 2024
A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis.
Journal: Blood cells, molecules & diseases
Published: November 19, 2021
Host and Graft Factors Impacting Infection Risk in Hematopoietic Cell Transplantation.
Journal: Infectious disease clinics of North America
Published: April 04, 2019
Hyperammonemia From Ureaplasma Infection in an Immunocompromised Child.
Journal: Journal of pediatric hematology/oncology
Published: February 22, 2019
Clinical characteristics and outcomes of PTLD following intestinal transplantation.
Journal: Clinical transplantation
Published: June 06, 2018
Creation and evaluation of a cancer survivorship curriculum for pediatric resident physicians.
Journal: Journal of cancer survivorship : research and practice
Published: April 09, 2018
Associations Between Pediatric Palliative Care Consultation and End-of-Life Preparation at an Academic Medical Center: A Retrospective EHR Analysis.
Journal: Hospital pediatrics
Published: February 14, 2018
Pre-clinical development of gene modification of haematopoietic stem cells with chimeric antigen receptors for cancer immunotherapy.
Journal: Human vaccines & immunotherapeutics
Published: January 07, 2017
Last Updated: 09/26/2026